(Press-News.org) HOUSTON – (Nov. 29, 2012) – Prostate cancer presents a dilemma for patients and the physicians who treat them. Which cancers are essentially indolent and present no risk and which are life threatening? Which can be watched and which need aggressive treatment?
Drs. Ming-Jer and Sophia Tsai, both professors in the department of molecular and cellular biology at Baylor College of Medicine, think a receptor called COUP-TFII that they have long studied may point the way to an answer. In a study that appears online in the journal Nature, they show that high levels (overexpression) of COUP-TFII can overcome a natural barrier to progression of prostate cancer, allowing tumor cells to grow and spread throughout the body – a process called metastasis.
"Levels of COUP-TFII provide a good prognostic marker for prostate cancer when added to other known markers of the disease," said Dr. Ming-Jer Tsai.
"COUP-TFII is an important 'second hit' for the progression of prostate cancer and metastasis," said Dr. Sophia Tsai. In other words, one "hit" or mutation might start the process of cells becoming cancerous. The second "hit" would make them more aggressive.
In studies of patient samples, loss of a protein called PTEN or mutations in another signaling pathway called PI3K show up in prostate tumors. However, tumors in which PTEN is lost can remain indolent. One theory is that loss of PTEN increases TGF-beta signaling, which creates a barrier to prostate cancer progression.
The Tsais' studies in mice that lack PTEN show that loss of COUP-TFII inhibits the development of prostate tumors in the animals. When mice have a gene that produces insufficient levels of PTEN, COUP-TFII overexpression enhances prostate tumor progression. Further studies in mice that lost PTEN showed that high levels of COUP-TFII promoted the metastatic spread of the prostate cancer.
Studies in cell cultures and in human tissues confirmed the activity of COUP-TFII in promoting a more aggressive form of prostate cancer that could spread and metastasize.
The next step is find out how to inhibit COUP-TFII and prevent so-called indolent prostate cancers from becoming more aggressive, said Ming-Jer Tsai.
###
Others who took part in this work include Jun Qin, San-Pin Wu, Fangyan Dai, Xin Xie, Chiang-Min Cheng, Chad J. Creighton, Anna Frolov, Gustavo Ayala, Xia Lin, Xin-Hua Feng and, Michael M. Ittmann, all of BCM and Shaw-Jenq Tsai of National Cheng Kung University College of Medicine in Tainan, Taiwan. Ayala is now with the University of Texas Medical School at Houston.
Funding for this study came from the National Institutes of Health (NIH DK62434, DK59820, DK45641 and HL76448).
Dr. Sophia Tsai holds the Gordon Cain Professorship and Dr. Ming-Jer Tsai holds the Charles C. Bell, Jr. and Distinguished Service Professorship in Cell Biology.
For more information on research at Baylor College of Medicine, please go to www.bcm.edu/fromthelab.
COUP-TFII sparks prostate cancer progression
2012-11-29
ELSE PRESS RELEASES FROM THIS DATE:
Genetic variation recent, varies among populations
2012-11-29
HOUSTON -- (Nov. 29, 2012) – Nearly three-quarters of mutations in genes that code for proteins – the workhorses of the cell – occurred within the past 5,000 to 10,000 years, fairly recently in evolutionary terms, said a national consortium of genomic and genetic experts, including those at Baylor College of Medicine.
"One of the most interesting points is that Europeans have more new deleterious (potentially disease-causing) mutations than Africans," said Dr. Suzanne Leal, professor of molecular and human genetics at BCM and an author of the report. She is also director ...
UC Davis researchers aid effort to sequence the complex wheat genome
2012-11-29
Intent on developing wheat varieties with higher yields and enhanced nutritional content, researchers at the University of California, Davis, have teamed up with scientists at nine other institutions in an attempt to sequence the wheat genome.
Results from that endeavor, led by researchers at the U.K.-based Biotechnology and Biological Sciences Research Council, will be reported Nov. 29 in the journal Nature.
"This work moves us one step closer to a comprehensive and highly detailed genome sequence for bread wheat, which along with rice and maize is one of the three ...
HIV treatment reduces risk of malaria recurrence in children, NIH funded study shows
2012-11-29
A combination of anti-HIV drugs has been found to also reduce the risk of recurrent malaria by nearly half among HIV-positive children, according to researchers supported by the National Institutes of Health.
The combination of protease inhibitors lopinavir and ritonavir contributed to an overall reduction of 40 percent in the rate of malaria among a group of HIV-positive infants and children up to 6 years old in Uganda who were also being treated with anti-malarial drugs. This reduction was in comparison to malaria incidence among children receiving a drug treatment ...
Johns Hopkins scientists pair blood test and gene sequencing to detect cancer
2012-11-29
Scientists at the Johns Hopkins Kimmel Cancer Center have combined the ability to detect cancer DNA in the blood with genome sequencing technology in a test that could be used to screen for cancers, monitor cancer patients for recurrence and find residual cancer left after surgery.
"This approach uses the power of genome sequencing to detect circulating tumor DNA in the blood, providing a sensitive method that can be used to detect and monitor cancers," says Victor Velculescu, M.D., Ph.D., professor of oncology and co-director of the Cancer Biology Program at Johns Hopkins.
A ...
Risk of childhood obesity can be predicted at birth
2012-11-29
A simple formula can predict at birth a baby's likelihood of becoming obese in childhood, according to a study published today in the open access journal PLOS ONE.
The formula, which is available as an online calculator, estimates the child's obesity risk based on its birth weight, the body mass index of the parents, the number of people in the household, the mother's professional status and whether she smoked during pregnancy.
The researchers behind the study hope their prediction method will be used to identify infants at high risk and help families take steps to ...
Liverpool scientists decipher genetic code of wheat
2012-11-29
Scientists at the University of Liverpool have deciphered the genetic code of wheat to help crop breeders increase yield and produce varieties that are better suited to a changing environment.
Wheat is one of the world's most important food crops, accounting for 20% of the world's calorific intake. Global wheat production, however, is under threat from climate change and an increase in demand from a growing human population.
The Liverpool team, at the University's Centre for Genomic Research, used new methods of sequencing DNA to decode the large wheat genome, ...
Testicular cancer risk tripled in boys whose testes fail to descend
2012-11-29
Boys whose testes have not descended at birth—a condition known as cryptorchidism—are almost three times as likely to develop testicular cancer in later life, finds an analysis of the available evidence published online in Archives of Disease in Childhood.
The findings prompt the authors to ask whether boys with the condition should be regularly monitored to lessen the potential risk
Cryptorchidsim, where testes fail to descend into the scrotum and are retained within the abdomen, is the most common birth defect in boys, affecting around 6% of newborns.
The authors ...
Texas astronomers measure most massive, most unusual black hole using Hobby-Eberly Telescope
2012-11-29
Fort Davis, Texas — Astronomers have used the Hobby-Eberly Telescope at The University of Texas at Austin's McDonald Observatory to measure the mass of what may be the most massive black hole yet — 17 billion Suns — in galaxy NGC 1277. The unusual black hole makes up 14 percent of its galaxy's mass, rather than the usual 0.1 percent. This galaxy and several more in the same study could change theories of how black holes and galaxies form and evolve. The work will appear in the journal Nature on Nov. 29.
NGC 1277 lies 220 million light-years away in the constellation Perseus. ...
Ponatinib acts against the most resistant types of chronic myeloid leukemia
2012-11-29
HOUSTON – A previously invincible mutation in chronic myeloid leukemia (CML) has been thwarted by an investigational drug in a phase I clinical trial reported in the current edition of The New England Journal of Medicine.
All 12 patients in the trial with chronic phase CML and the T315I mutation had a complete hematologic response (absence of CML cells in the blood) after treatment with ponatinib. Eleven had a major reduction in CML cells in the bone marrow and nine achieved a complete cytogenetic response – no cells in the marrow.
T315I is present in up to 20 percent ...
In Cedars-Sinai study, common drug reverses common effect of Becker muscular dystrophy
2012-11-29
LOS ANGELES (Nov. 28, 2012) – Cedars-Sinai Heart Institute researchers have found in an initial clinical trial that a drug typically prescribed for erectile dysfunction or pulmonary hypertension restores blood flow to oxygen-starved muscles in patients with a type of muscular dystrophy that affects males, typically starting in childhood or adolescence.
Tadalafil, commonly known by brand names Cialis and Adcirca, reversed the effects of a biochemical chain of events that in Becker muscular dystrophy deprives muscles of an important chemical, nitric oxide, which normally ...